Real-time enrollment status for this angelman syndrome clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:57 AM UTC
| NCT Number | NCT06914609 |
| Recruiting Status | Recruiting |
| Condition | Angelman Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 158 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Ionis Pharmaceuticals, Inc. |
| Last Updated on CT.gov | June 23, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT06914609 is currently recruiting participants. This phase3 study for angelman syndrome is actively seeking new participants at 17 locations across the United States. The study is sponsored by Ionis Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06914609 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06914609 was last updated 3 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.